Delivery Order SPE2DB24D1205-SPE2DB25FCZMJ
Award Date 8/13/25
Potential Completion Date 9/4/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Leqembi 500 mg/5 ml vials with a ceiling value of $2,188.25 and an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical prime vendor agreement valued through...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,136.57 for LEQEMBI 200 mg/2 ml vials by the Department of Defense Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. LEQEMBI is a specialized...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,186.60 firm fixed-price contract is for the delivery of LEQEMBI 500 MG/5 ML VIAL 5ML, a medical supply product. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, LEQEMBI 500 MG/5 ML VIAL 5ML, with a ceiling value of $2,188.25. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,068.56 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Likmez 500 mg/5 mL suspension in 200 mL quantities. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Likmez 500 mg/5 mL suspension in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,298.44 and an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order worth $2,197.41 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,993.76 to AmerisourceBergen Drug Corp for the supply of LIKMEZ 500 mg/5 mL suspension in 200 mL quantities. This firm fixed-price contract was competitively awarded without set-aside designation and is set for completion by July 24, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,302.20 delivery order contract is for the supply of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a firm fixed-price arrangement with a period of performance through May 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...